222 related articles for article (PubMed ID: 33949246)
1. The epidemiology of mescaline use: Pattern of use, motivations for consumption, and perceived consequences, benefits, and acute and enduring subjective effects.
Uthaug MV; Davis AK; Haas TF; Davis D; Dolan SB; Lancelotta R; Timmermann C; Ramaekers JG
J Psychopharmacol; 2022 Mar; 36(3):309-320. PubMed ID: 33949246
[TBL] [Abstract][Full Text] [Related]
2. Naturalistic Use of Mescaline Is Associated with Self-Reported Psychiatric Improvements and Enduring Positive Life Changes.
Agin-Liebes G; Haas TF; Lancelotta R; Uthaug MV; Ramaekers JG; Davis AK
ACS Pharmacol Transl Sci; 2021 Apr; 4(2):543-552. PubMed ID: 33860184
[TBL] [Abstract][Full Text] [Related]
3. The epidemiology of 5-methoxy- N, N-dimethyltryptamine (5-MeO-DMT) use: Benefits, consequences, patterns of use, subjective effects, and reasons for consumption.
Davis AK; Barsuglia JP; Lancelotta R; Grant RM; Renn E
J Psychopharmacol; 2018 Jul; 32(7):779-792. PubMed ID: 29708042
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic and Pharmacodynamic Aspects of Peyote and Mescaline: Clinical and Forensic Repercussions.
Dinis-Oliveira RJ; Pereira CL; da Silva DD
Curr Mol Pharmacol; 2019; 12(3):184-194. PubMed ID: 30318013
[TBL] [Abstract][Full Text] [Related]
5. An Overview on the Hallucinogenic Peyote and Its Alkaloid Mescaline: The Importance of Context, Ceremony and Culture.
Doesburg-van Kleffens M; Zimmermann-Klemd AM; Gründemann C
Molecules; 2023 Dec; 28(24):. PubMed ID: 38138432
[TBL] [Abstract][Full Text] [Related]
6. Dark Classics in Chemical Neuroscience: Mescaline.
Cassels BK; Sáez-Briones P
ACS Chem Neurosci; 2018 Oct; 9(10):2448-2458. PubMed ID: 29847089
[TBL] [Abstract][Full Text] [Related]
7. Perceived outcomes of psychedelic microdosing as self-managed therapies for mental and substance use disorders.
Lea T; Amada N; Jungaberle H; Schecke H; Scherbaum N; Klein M
Psychopharmacology (Berl); 2020 May; 237(5):1521-1532. PubMed ID: 32043165
[TBL] [Abstract][Full Text] [Related]
8. Psychedelics and mental health: a population study.
Krebs TS; Johansen PØ
PLoS One; 2013; 8(8):e63972. PubMed ID: 23976938
[TBL] [Abstract][Full Text] [Related]
9. Mescaline: a survey.
Schwartz RH
Am Fam Physician; 1988 Apr; 37(4):122-4. PubMed ID: 3358338
[TBL] [Abstract][Full Text] [Related]
10. Peyote and mescaline exposures: a 12-year review of a statewide poison center database.
Carstairs SD; Cantrell FL
Clin Toxicol (Phila); 2010 May; 48(4):350-3. PubMed ID: 20170392
[TBL] [Abstract][Full Text] [Related]
11. 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) used in a naturalistic group setting is associated with unintended improvements in depression and anxiety.
Davis AK; So S; Lancelotta R; Barsuglia JP; Griffiths RR
Am J Drug Alcohol Abuse; 2019; 45(2):161-169. PubMed ID: 30822141
[TBL] [Abstract][Full Text] [Related]
12. Development of the Psychological Insight Questionnaire among a sample of people who have consumed psilocybin or LSD.
Davis AK; Barrett FS; So S; Gukasyan N; Swift TC; Griffiths RR
J Psychopharmacol; 2021 Apr; 35(4):437-446. PubMed ID: 33427007
[TBL] [Abstract][Full Text] [Related]
13. Connected to the spirit of the frog: An Internet-based survey on Kambô, the secretion of the Amazonian Giant Maki Frog (
Majić T; Sauter M; Bermpohl F; Schmidt TT
J Psychopharmacol; 2021 Apr; 35(4):421-436. PubMed ID: 33663248
[TBL] [Abstract][Full Text] [Related]
14. The analysis and distribution of mescaline in postmortem tissues.
Henry JL; Epley J; Rohrig TP
J Anal Toxicol; 2003 Sep; 27(6):381-2. PubMed ID: 14516493
[TBL] [Abstract][Full Text] [Related]
15. An Efficient Ambient Ionization Mass Spectrometric Approach to Detection and Quantification of the Mescaline Content of Commonly Abused Cacti from the Echinopsis Genus.
Longo CM; Musah RA
J Forensic Sci; 2020 Jan; 65(1):61-66. PubMed ID: 31310334
[TBL] [Abstract][Full Text] [Related]
16. GC-MS and GC-MS/MS in PCI mode determination of mescaline in peyote tea and in biological matrices.
Gambelunghe C; Marsili R; Aroni K; Bacci M; Rossi R
J Forensic Sci; 2013 Jan; 58(1):270-8. PubMed ID: 22900815
[TBL] [Abstract][Full Text] [Related]
17. Ecstasy analogues found in cacti.
Bruhn JG; El-Seedi HR; Stephanson N; Beck O; Shulgin AT
J Psychoactive Drugs; 2008 Jun; 40(2):219-22. PubMed ID: 18720674
[TBL] [Abstract][Full Text] [Related]
18. Illicit peyote use among American Indian adolescents in substance abuse treatment: a preliminary investigation.
Fickenscher A; Novins DK; Manson SM
Subst Use Misuse; 2006; 41(8):1139-54. PubMed ID: 16798681
[TBL] [Abstract][Full Text] [Related]
19. Psychedelic drugs, stress, and the ego. The differential diagnosis of psychosis associated with psychotomimetic drug use.
Glass GS
J Nerv Ment Dis; 1973 Apr; 156(4):232-41. PubMed ID: 4708883
[No Abstract] [Full Text] [Related]
20. Blood flow and cerebral laterality in the mescaline model of psychosis.
Hermle L; Gouzoulis-Mayfrank E; Spitzer M
Pharmacopsychiatry; 1998 Jul; 31 Suppl 2():85-91. PubMed ID: 9754839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
